Fig 1: Ratio of increase of cytokines (a) IL-33, (b) IL-25, (c) TSLP, (d) IFN-γ, (e) TNF-α, (f) IL-13 and (g) IL-4 in S and L sites. Graphs represent the normalized concentration of one cytokine on S/L site divided by the normalized concentration of this cytokine in C or V/NL site for the experimental model of canine AD/dogs affected spontaneously with canine AD. C = control site, V = vehicle site, S = sensitized site, NL = nonlesional site, L = lesional site. * p < 0.05, ** p < 0.001, *** p < 0.0001.
Fig 2: Mean concentration expression of (a) IL-33, (b) IL-25, (c) TSLP, (d) IFN-γ, (e) TNF-α, (f) IL-13, and (g) IL-4 on L and NL sites in dogs spontaneously affected with AD. NL = nonlesional site, L= lesional site. * p < 0.05, ** p < 0.001.
Fig 3: Mean concentration expression of (a) IL-33, (b) IL-25, (c) TSLP, (d) IFN-γ, (e) TNF-α, (f) IL-13, and (g) IL-4 on C, V, and S sites in canine model of AD. C = control site, V = vehicle site, S = sensitized site. * p < 0.05, ** p < 0.001, *** p < 0.0001.
Fig 4: Mean concentration expression of (a) IL-33, (b) IL-25, (c) TSLP, (d) IFN-γ, (e) TNF-α, (f) IL-13, and (g) IL-4 on C, V, and S sites in canine model of AD. C = control site, V = vehicle site, S = sensitized site. * p < 0.05, ** p < 0.001, *** p < 0.0001.
Fig 5: Ratio of increase of cytokines (a) IL-33, (b) IL-25, (c) TSLP, (d) IFN-γ, (e) TNF-α, (f) IL-13 and (g) IL-4 in S and L sites. Graphs represent the normalized concentration of one cytokine on S/L site divided by the normalized concentration of this cytokine in C or V/NL site for the experimental model of canine AD/dogs affected spontaneously with canine AD. C = control site, V = vehicle site, S = sensitized site, NL = nonlesional site, L = lesional site. * p < 0.05, ** p < 0.001, *** p < 0.0001.
Supplier Page from Biorbyt for Dog IL33 ELISA Kit
Application Notes: Detection Wavelength: 450 nm